Ulf Schönermarck

Consultant
Klinikum der Universität München – Medizinische Klinik und Poliklinik IV, Nephrologisches Zentrum, Munich, Germany

Presentation(s):

• PB0303 - Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpura

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM